Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
The Newswire

Izotropic Finalizes Engineering and Development Transition to the United States; Establishes Operations in Primary Target Market

    

VANCOUVER, BC – TheNewswire - August 11, 2022 – Izotropic Corporation ("Izotropic" or the "Company") (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a MedTech company commercializing IzoView, an advanced three-dimensional computed tomography (3D CT) breast imaging platform for the more accurate detection and diagnosis of breast cancer, is pleased to report the Company has successfully relocated IzoView and associated components and completed the transition of all major medical device engineering and product development operations to California.

Further to the Company's prior announcement, the move to relocate commercial development of IzoView to Sacramento, CA was made to help accelerate testing and optimization of the device as the Company prepares for its upcoming clinical study and submission for market authorization in the U.S.  

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.